341 related articles for article (PubMed ID: 17240182)
21. Aromatic L-amino acid decarboxylase deficiency associated with epilepsy mimicking non-epileptic involuntary movements.
Ito S; Nakayama T; Ide S; Ito Y; Oguni H; Goto Y; Osawa M
Dev Med Child Neurol; 2008 Nov; 50(11):876-8. PubMed ID: 18754761
[TBL] [Abstract][Full Text] [Related]
22. Expression, purification, and characterization of rat aromatic L-amino acid decarboxylase in Escherichia coli.
Jebai F; Hanoun N; Hamon M; Thibault J; Peltre G; Gros F; Krieger M
Protein Expr Purif; 1997 Nov; 11(2):185-94. PubMed ID: 9367815
[TBL] [Abstract][Full Text] [Related]
23. Aromatic L-amino acid decarboxylase deficiency diagnosed by clinical metabolomic profiling of plasma.
Atwal PS; Donti TR; Cardon AL; Bacino CA; Sun Q; Emrick L; Reid Sutton V; Elsea SH
Mol Genet Metab; 2015; 115(2-3):91-4. PubMed ID: 25956449
[TBL] [Abstract][Full Text] [Related]
24. Blood, urine and cerebrospinal fluid analysis in TH and AADC deficiency and the effect of treatment.
Wassenberg T; Geurtz BPH; Monnens L; Wevers RA; Willemsen MA; Verbeek MM
Mol Genet Metab Rep; 2021 Jun; 27():100762. PubMed ID: 33996491
[TBL] [Abstract][Full Text] [Related]
25. L-dopa as substrate for human duodenal catechol-O-methyltransferase and aromatic L-amino acid decarboxylase.
Schultz E
Biomed Chromatogr; 1990 Nov; 4(6):242-4. PubMed ID: 2289048
[TBL] [Abstract][Full Text] [Related]
26. L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase.
Shimamura M; Shimizu M; Yagami T; Funabashi T; Kimura F; Kuroiwa Y; Misu Y; Goshima Y
Neuropharmacology; 2006 Jun; 50(8):909-16. PubMed ID: 16504219
[TBL] [Abstract][Full Text] [Related]
27. A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels.
Ogawa A; Kanazawa M; Takayanagi M; Kitani Y; Shintaku H; Kohno Y
Brain Dev; 2008 Jan; 30(1):82-5. PubMed ID: 17590551
[TBL] [Abstract][Full Text] [Related]
28. Semi-quantitative detection of a vanillactic acid/vanillylmandelic acid ratio in urine is a reliable diagnostic marker for aromatic L-amino acid decarboxylase deficiency.
Brennenstuhl H; Garbade SF; Okun JG; Feyh P; Hoffmann GF; Langhans CD; Opladen T
Mol Genet Metab; 2020; 131(1-2):163-170. PubMed ID: 32675002
[TBL] [Abstract][Full Text] [Related]
29. Pyridoxal 5'-phosphate deficiency causes a loss of aromatic L-amino acid decarboxylase in patients and human neuroblastoma cells, implications for aromatic L-amino acid decarboxylase and vitamin B(6) deficiency states.
Allen GF; Neergheen V; Oppenheim M; Fitzgerald JC; Footitt E; Hyland K; Clayton PT; Land JM; Heales SJ
J Neurochem; 2010 Jul; 114(1):87-96. PubMed ID: 20403077
[TBL] [Abstract][Full Text] [Related]
30. Unusually mild phenotype of AADC deficiency in 2 siblings.
Tay SK; Poh KS; Hyland K; Pang YW; Ong HT; Low PS; Goh DL
Mol Genet Metab; 2007 Aug; 91(4):374-8. PubMed ID: 17533144
[TBL] [Abstract][Full Text] [Related]
31. Reaction of dopa decarboxylase with L-aromatic amino acids under aerobic and anaerobic conditions.
Bertoldi M; Borri Voltattorni C
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):533-8. PubMed ID: 11085948
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive urinary screening for aromatic L-amino acid decarboxylase deficiency in high-prevalence areas: a pilot study.
Lee HC; Lai CK; Yau KC; Siu TS; Mak CM; Yuen YP; Chan KY; Tam S; Lam CW; Chan AY
Clin Chim Acta; 2012 Jan; 413(1-2):126-30. PubMed ID: 21963339
[TBL] [Abstract][Full Text] [Related]
33. Gene therapy for aromatic L-amino acid decarboxylase deficiency.
Hwu WL; Muramatsu S; Tseng SH; Tzen KY; Lee NC; Chien YH; Snyder RO; Byrne BJ; Tai CH; Wu RM
Sci Transl Med; 2012 May; 4(134):134ra61. PubMed ID: 22593174
[TBL] [Abstract][Full Text] [Related]
34. [Molecular genetics of aromatic L-amino acid decarboxylase].
Ichinose H; Nagatsu T
Yakubutsu Seishin Kodo; 1993 Aug; 13(4):251-6. PubMed ID: 8237142
[TBL] [Abstract][Full Text] [Related]
35. Fibroblasts that express aromatic amino acid decarboxylase have increased sensitivity to the synergistic cytotoxicity of L-dopa and manganese.
Montine TJ; Underhill TM; Linney E; Graham DG
Toxicol Appl Pharmacol; 1994 Sep; 128(1):116-22. PubMed ID: 8079344
[TBL] [Abstract][Full Text] [Related]
36. Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia.
Abeling NG; Duran M; Bakker HD; Stroomer L; Thöny B; Blau N; Booij J; Poll-The BT
Mol Genet Metab; 2006; 89(1-2):116-20. PubMed ID: 16650784
[TBL] [Abstract][Full Text] [Related]
37. A female case of aromatic l-amino acid decarboxylase deficiency responsive to MAO-B inhibition.
Kojima K; Anzai R; Ohba C; Goto T; Miyauchi A; Thöny B; Saitsu H; Matsumoto N; Osaka H; Yamagata T
Brain Dev; 2016 Nov; 38(10):959-963. PubMed ID: 27371992
[TBL] [Abstract][Full Text] [Related]
38. Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.
Buck K; Ferger B
Neurobiol Dis; 2008 Feb; 29(2):210-20. PubMed ID: 17920284
[TBL] [Abstract][Full Text] [Related]
39. Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterin.
McInnes RR; Kaufman S; Warsh JJ; Van Loon GR; Milstien S; Kapatos G; Soldin S; Walsh P; MacGregor D; Hanley WB
J Clin Invest; 1984 Feb; 73(2):458-69. PubMed ID: 6142058
[TBL] [Abstract][Full Text] [Related]
40. Aromatic L-amino acid decarboxylase-immunoreactive structures in human midbrain, pons, and medulla.
Kitahama K; Ikemoto K; Jouvet A; Araneda S; Nagatsu I; Raynaud B; Nishimura A; Nishi K; Niwa S
J Chem Neuroanat; 2009 Oct; 38(2):130-40. PubMed ID: 19589383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
